Market Research Report Store Mast Therapeutics Inc (MSTX) – Pharmaceuticals & H | Page 4

Mast Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017
Mast Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details
Partnerships
9
10
10
Aires Pharma Enters into Agreement with University of Pittsburgh
10
ADVENTRX Pharma and Pierre Fabre Medicament Enter into Agreement for ANX-188 10
Merger
11
Mast Therapeutics Merges with Savara
Equity Offering
11
12
Mast Therapeutics Raises USD8 Million in Public Offering of Units
12
Mast Therapeutics to Raise up to USD30 Million in Public Offering of Shares 14
Mast Therapeutics Raises USD15 Million in Public Offering of Series A Units 15
Mast Therapeutics Raises USD6 Million in Public Offering of Series B Units
Mast Therapeutics Completes Public Offering Of Units For US$28 Million
17
18
ADVENTRX Files Registration Statement For Public Offering Of Securities For US$150 Million
20
ADVENTRX Pharma Completes Underwritten Public Offering Of Common Stock For US$17 Million
21
ADVENTRX Pharma Completes Registered Direct Offering Of Its Units For US$22.5 Million
Acquisition
23
Mast Therapeutics Completes Acquisition Of Aires Pharma
23
Adventrx Pharma Completes Acquisition Of SynthRx From CytRx
ADVENTRX To Acquire A Pharma Company
Mast Therapeutics Inc - Key Competitors
Key Employees
29
Locations And Subsidiaries 30
28
26
24
22